The principal goal of Avatar is to provide specialist insurance broking services to companies that develop innovative technology. Our key advantage is objective, in-depth research on industry-specific exposures. Avatar understands the unique requirements of your industry & takes the time to understand the specific issues & challenges facing your business. Avatar’s notable expertise in the life sciences & technology sector aims to deliver real financial and business benefits.

Brandon Capital is Australasia's leading life science venture capital firm, with a strong global presence supported by key partnerships and team members across the US and UK.

CMRI is an independent organisation with over 170 scientists committed to finding treatments and cures for serious conditions affecting kids. We aim to make the incurable curable.

Cube is a privately owned, Sydney-based public relations and communications agency, specialising and excelling in healthcare since 2004. Our unique and energetic team focus on strategic communications solutions grounded in science. They deliver fully integrated campaigns across ethical pharmaceuticals and consumer healthcare sectors.

FB Rice is Australia’s most trusted intellectual property firm with offices across the country and an established presence across New Zealand and South-East Asia.

Our patented antibodies target Glypican-1 (GPC-1), a protein overexpressed in prostate, pancreatic, bladder, glioblastoma, esophageal, lung and ovarian cancers. Importantly, there is no antibody reactivity in normal tissues. We have now completed a First-in-Human trial in Australia using Miltuximab®, our anti-GPC-1 monoclonal antibody (ANZCTR registry). The trial dosed 12 patients and no drug-related adverse events were observed.

Intuitive was established to provide expert advice, personal service, and tailored insurance solutions to clients, particularly with complex risk profiles. We build close relationships with clients in the role of a trusted risk advisor, enabling a more proactive approach to risk management in an ever-changing business environment.

Minomic International Ltd is an Australian immuno-oncology company that has developed an in vitro diagnostic test for the early detection of prostate cancer. The test, known as MiCheck® detects biomarkers present in the blood of patients.

SCT provides a dedicated, superior central laboratory service, exclusively in support of Phase I-IV clinical trials, safety testing and patient monitoring services to the Pharmaceutical, Biotechnology and Research organisations in the Asia Pacific region.

Spruson & Ferguson is a leading provider of intellectual property (IP) services across the Asia-Pacific region. We have been providing expert representation in all aspects of IP since 1887. Our long history has allowed us to build robust infrastructure, supported by sophisticated systems and highly skilled and experienced teams.

With our expertise in specialty healthcare logistics, we deliver advanced medical courier services. We cater to pharma companies globally, ensuring seamless transportation of critical healthcare products.